Organon holds special shareholder meeting on merger agreement proposal

• Organon held a special shareholder meeting on July 23, 2026 to vote on a merger agreement with Sun Pharmaceutical Holdings USA.
• Shareholders adopted the merger agreement, authorizing the transaction to proceed subject to completion of the merger.
• Investors also backed a non-binding advisory resolution on merger-related executive compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-314587), on July 23, 2026, and is solely responsible for the information contained therein.